ConductScience.org, home

Paper973974

Agonist and antagonist effects of Sar1-ala8--angiotensin II in salt-loaded and salt-depleted normal man.

MacGregor GA and 1 other. Br J Clin Pharmacol, 1976. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. Agonist and antagonist effects of Sar1-ala8--angiotensin II in salt-loaded and salt-depleted normal man. Papers, record 973974. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/973974

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Agonist and antagonist effects of Sar1-ala8--angiotensin II in salt-loaded and salt-depleted normal man.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1976
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
1.11
iCite
Revised in PubMed
2019-05-09
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1MacGregor GAG A
2Dawes PMP M

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Angiotensin IIMajor topic
SaralasinMajor topic
Sodium ChlorideMajor topic
Blood Pressure
Diet
Diuresis
Dose-Response Relationship, Drug
Glomerular Filtration Rate
Humans
Kidney
Male
Regional Blood Flow
Renin
Sodium

Source PubMed

Download CSV of topics

References6

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1235090Use of an angiotensin II antagonist (saralasin) in the recognition of "angiotensinogenic" hypertension;.N Engl J Med1975https://conductscience.org/library/papers/235090PubMed
24127309Angiotensin-II blockade in man by sar1-ala8-angiotensin II for understanding and treatment of high blood-pressure.Lancet1973https://conductscience.org/library/papers/4127309PubMed
316695909ANGIOTENSIN II, NOREPINEPHRINE, AND RENAL TRANSPORT OF ELECTROLYTES AND WATER IN NORMAL MAN AND IN CIRRHOSIS WITH ASCITES.J Clin Invest1963https://conductscience.org/library/papers/16695909PubMed
44358849Characterization of smooth muscle receptors for angiotensin: studies with an antagonist.Am J Physiol1974https://conductscience.org/library/papers/4358849PubMed
513873671The effect of angiotension on urine flow and electrolyte excretion in hypertensive patients.Clin Sci1962https://conductscience.org/library/papers/13873671PubMed
64333501Estimation of angiotensin II concentration in human plasma by radioimmunoassay. Some applications to physiological and clinical states.Eur J Clin Invest1971https://conductscience.org/library/papers/4333501PubMed

Download CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
6269679Captopril and the maintenance of blood pressure after sinoaortic denervation in the rabbit.Br J Pharmacol1981https://conductscience.org/library/papers/6269679PubMed
1000214Angiotensin II blockade with saralasin.Br Med J1976https://conductscience.org/library/papers/1000214PubMed
916618[Hemodynamic effects of sar1-ala8-angiotensin in patients with renovascular hypertension (author's transl)].Klin Wochenschr1977https://conductscience.org/library/papers/916618PubMed
732257Pharmacokinetic and pharmacodynamic studies of infusions with [Sar 1, Val5, Ala8] angiotensin II (saralasin).Klin Wochenschr1978https://conductscience.org/library/papers/732257PubMed
729612The effect of angiotensin II blockade by saralasin (1-Sar-8-Ala-angiotensin II) in normal man.Eur J Clin Pharmacol1978https://conductscience.org/library/papers/729612PubMed
229941Essential hypertension: effect of an oral inhibitor of angiotensin-converting enzyme.Br Med J1979https://conductscience.org/library/papers/229941PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AGT183PubTator's text mininghttps://conductscience.org/library/genes/183NCBI Gene
REN5972PubTator's text mininghttps://conductscience.org/library/genes/5972NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/973974

GET https://conductscience.org/api/papers/v1/973974/authors